Online citations, reference lists, and bibliographies.
← Back to Search

Recent Development In Biodegradable Nanovehicle Delivery System-assisted Immunotherapy.

Zhenfu Wen, F. Liu, Q. Chen, Y. Xu, H. Li, Shiguo Sun
Published 2019 · Computer Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Based on the stimulation of the patient's own innate and adaptive immunity, immunotherapy is used in tumor treatment, and in recent years, it has developed rapidly. To generate strong and long-lasting antitumor immune responses and to boost clinical efficiency, various nanovehicle delivery systems (NDSs) have been designed to achieve specific release and avoid premature leakage in the delivery process. However, most of them are nondegradable, and they are taken up by the liver and spleen. This process leads to the accumulation of these substances in the human body, raising long-term toxicity concerns and causing potential undesirable side effects. To solve this problem, biodegradable NDSs (BNDSs) have been developed. Once these substances reach their target, they can only be degraded under specific internal or external stimuli, such as enzymes, irradiation, temperature, redox potential, pH, or a combination of these stimuli. Therefore, they are quite significant for potential clinical applications. In this review article, we highlight the recent literature on the design and working mechanism of various BNDSs. According to their type and characteristics, BNDSs are categorized as follows: (1) polymers, (2) lipid based materials, (3) inorganic nanomaterials, (4) biomacromolecules, (5) hybrid materials and (6) other materials. The existing challenges and future prospects of these materials will also be discussed.
This paper references
10.1016/j.biomaterials.2013.12.024
Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy.
E. Yuba (2014)
10.1007/s00262-013-1411-0
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles
Rodney A. Rosalia (2013)
10.1002/ADFM.201800025
iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
Jing Kuang (2018)
10.1016/j.nano.2017.08.010
Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies.
A. R. Nikpoor (2017)
10.1016/j.nano.2011.10.014
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer.
D. Vergara (2012)
10.7150/thno.19987
Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
Miao Kong (2017)
10.1021/acsnano.7b04955
Biomimetic Magnetosomes as Versatile Artificial Antigen-Presenting Cells to Potentiate T-Cell-Based Anticancer Therapy.
Qianmei Zhang (2017)
10.1039/c3nr34006f
Self-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery.
Xiaoliang Fang (2013)
10.1016/j.biomaterials.2014.07.055
Polarized immune responses modulated by layered double hydroxides nanoparticle conjugated with CpG.
Shiyu Yan (2014)
10.1177/0284185118757575
Uterine artery embolization in a sheep model: biodegradable versus non-degradable microspheres
I. Keussen (2018)
10.1038/nrc1894
Photodynamic therapy and anti-tumour immunity
A. Castano (2006)
10.1016/j.actbio.2013.12.050
Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
M. Heo (2014)
10.1166/JBN.2014.2051
Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
C. Lai (2014)
10.1016/S0169-409X(97)00048-3
Biodegradation and biocompatibility of PLA and PLGA microspheres
J. Anderson (1997)
10.1038/ncomms12499
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He (2016)
10.1002/ADFM.201703303
Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
Tomás Bauleth-Ramos (2017)
10.1016/j.jconrel.2016.12.012
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
F. Jadidi-Niaragh (2017)
10.18632/ONCOTARGET.2195
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
I. Segatto (2014)
10.1002/(SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3
Tumor‐infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
L. Lespagnard (1999)
10.1016/J.MICROMESO.2018.12.001
BSA modified, disulfide-bridged mesoporous silica with low biotoxicity for dual-responsive drug delivery
Junna Lu (2019)
10.1002/ADFM.201404511
Design of Hybrid MnO2‐Polymer‐Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment
C. Gordijo (2015)
10.1021/acsnano.7b09112
Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication.
Wen Song (2018)
10.1039/c4nr00070f
Iron oxide superparamagnetic nanoparticles conjugated with a conformationally blocked α-Tn antigen mimetic for macrophage activation.
M. Manuelli (2014)
10.1016/S1748-0132(07)70083-X
Targeted nanoparticles for cancer therapy
F. Gu (2007)
10.1046/J.1523-1747.1999.00745.X
Absorption of hyaluronan applied to the surface of intact skin.
T. Brown (1999)
10.1002/adma.201703178
Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T-Cells.
F. S. Majedi (2018)
10.1208/s12248-014-9686-4
Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
E. Varypataki (2014)
10.7150/thno.14471
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors
Brian T. Luk (2016)
10.1158/0008-5472.CAN-15-1591
Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.
S. Tohme (2016)
10.1007/s11671-009-9413-8
The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction
Cory Hanley (2009)
10.1002/adma.201604634
Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles.
Jonas G. Croissant (2017)
10.1080/09687860600790537
Immunostimulation of dendritic cells by cationic liposomes
D. P. Vangasseri (2006)
10.1016/j.biomaterials.2010.08.107
The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response.
A. Li (2011)
10.1021/ac302463p
Functional protein microarrays by electrohydrodynamic jet printing.
Kazuyo Shigeta (2012)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1038/NATREVMATS.2016.14
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm (2016)
10.1039/c3nr04421a
Functionalized iron oxide nanoparticles for controlling the movement of immune cells.
Ethan E. White (2015)
10.1016/j.biomaterials.2015.12.007
Self-adjuvanted hyaluronate--antigenic peptide conjugate for transdermal treatment of muscular dystrophy.
W. H. Kong (2016)
10.1016/j.ijpharm.2015.08.048
Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model.
Amin Reza Nikpoor (2015)
10.1016/j.immuni.2018.03.017
Manganese Increases the Sensitivity of the cGAS‐STING Pathway for Double‐Stranded DNA and Is Required for the Host Defense against DNA Viruses
C. Wang (2018)
10.1016/0032-3861(95)94340-Y
Differential scanning calorimetry investigation of phase transitions in water/ chitosan systems
J. Ratto (1995)
10.1021/acsnano.7b04736
Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes.
Xinhe Yu (2017)
10.1021/nn5002112
Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
Liangran Guo (2014)
10.2217/nnm.15.213
Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.
Rutika A Kokate (2016)
10.2741/3520
Molecular mechanisms of photodynamic therapy.
B. Ortel (2009)
10.1016/j.biomaterials.2017.01.017
A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
F. Duan (2017)
10.1021/acsnano.7b01786
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer.
Lei Miao (2017)
10.1021/MP034002C
Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles.
J. Panyam (2004)
10.1021/acsnano.5b07973
Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy.
Stefanie U. Frick (2016)
10.1166/JNN.2016.10714
Dendritic Cells Stimulated by Cationic Liposomes.
M. T. Vitor (2016)
10.1016/j.ijpharm.2017.11.031
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation.
Jérôme Widmer (2018)
10.1016/S0014-5793(02)03408-7
Biophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery
K. Jørgensen (2002)
10.1016/j.biomaterials.2013.12.018
Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin.
W. Song (2014)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1016/j.biomaterials.2013.09.050
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
J. Sunshine (2014)
10.1039/c7cs00263g
Microfluidic fabrication of microparticles for biomedical applications.
Wangrong Li (2018)
10.1016/j.biomaterials.2015.04.043
Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer.
S. Rahimian (2015)
10.1016/j.critrevonc.2013.07.008
Surgery, wound healing, and metastasis: recent insights and clinical implications.
W. Ceelen (2014)
10.1016/S0168-3659(99)00114-5
The design and synthesis of polymers for eukaryotic membrane disruption.
N. Murthy (1999)
10.1021/acsnano.7b05465
Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Y. Qian (2017)
10.1002/smll.201701816
Hollow ZnO Nanospheres Enhance Anticancer Immunity by Promoting CD4+ and CD8+ T Cell Populations In Vivo.
Xiupeng Wang (2017)
10.3390/cancers6031670
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee (2014)
10.1021/acs.nanolett.5b05030
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.
C. Wang (2016)
10.1016/j.colsurfb.2015.04.013
Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
M. Y. Want (2015)
10.1038/s41467-018-03915-4
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
T. Wang (2018)
10.1016/J.DRUDIS.2006.07.005
Exploiting the enhanced permeability and retention effect for tumor targeting.
A. Iyer (2006)
10.1039/B808030E
Materials science of DNA
Y. W. Kwon (2011)
10.1002/ADFM.201600650
Metal‐Organic‐Framework‐Based Vaccine Platforms for Enhanced Systemic Immune and Memory Response
Y. Zhang (2016)
10.1016/j.biomaterials.2016.07.005
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy
H. Hassan (2016)
10.1016/j.biomaterials.2014.05.077
Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Y. Yoshizaki (2014)
10.18632/ONCOTARGET.1820
Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytes-mediated cytotoxicity
M. Shevtsov (2014)
10.1002/ADMA.201101646
Clicking well-defined biodegradable nanoparticles and nanocapsules by UV-induced thiol-ene cross-linking in transparent miniemulsions.
Jiong Zou (2011)
10.1021/acs.nanolett.7b03186
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy.
Qingle Song (2017)
10.1039/c5nr03065j
Enzymatically degradable hybrid organic-inorganic bridged silsesquioxane nanoparticles for in vitro imaging.
Yevhen Fatieiev (2015)
10.1073/pnas.0901592106
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Kyle E Broaders (2009)
10.1016/j.jconrel.2013.05.037
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes.
Y. Zheng (2013)
10.1016/j.biomaterials.2016.11.038
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.
A. Kosmides (2017)
10.1002/adma.201304821
25th anniversary article: materials for high-performance biodegradable semiconductor devices.
Suk-Won Hwang (2014)
10.1016/j.biomaterials.2017.11.048
Nanoantagonists with nanophase-segregated surfaces for improved cancer immunotherapy.
Y. Ma (2018)
10.1002/smll.201701864
Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
X. Sun (2017)
10.1158/0008-5472.CAN-13-1196
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.
Damya Laoui (2014)
10.1038/nrc4015
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman (2015)
10.1172/JCI44490
An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.
A. Sindrilaru (2011)
10.1002/adma.201801527
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade.
Shuangjiang Yu (2018)
10.1016/j.biomaterials.2016.03.009
Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection.
Z. Huang (2016)
10.1016/j.biomaterials.2017.10.013
Successful transdermal allergen delivery and allergen-specific immunotherapy using biodegradable microneedle patches.
J. E. Kim (2018)
10.1002/jbm.b.32711
Degradation of hollow mesoporous silica nanoparticles in human umbilical vein endothelial cells.
Wanyin Zhai (2012)
10.1002/adma.201405141
Intelligent MnO2 Nanosheets Anchored with Upconversion Nanoprobes for Concurrent pH-/H2O2-Responsive UCL Imaging and Oxygen-Elevated Synergetic Therapy.
W. Fan (2015)
10.1021/jacs.8b01072
Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy.
Guangxu Lan (2018)
10.1056/NEJMOA1606774
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
M. Reck (2016)
10.1016/j.jconrel.2011.09.064
Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review.
Tapan K. Dash (2012)
10.1016/j.jconrel.2008.05.021
Subcellular compartment targeting of layered double hydroxide nanoparticles.
Z. P. Xu (2008)
10.1002/ADFM.201505188
Enzyme-Catalyzed Formation of Supramolecular Hydrogels as Promising Vaccine Adjuvants
H. Wang (2016)
10.1126/scitranslmed.aar1916
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
C. Park (2018)
10.1038/srep38931
Construction of A Triple-Stimuli-Responsive System Based on Cerium Oxide Coated Mesoporous Silica Nanoparticles
J. Wen (2016)
10.1126/science.342.6165.1432
Breakthrough of the year 2013. Cancer immunotherapy.
J. Couzin-Frankel (2013)
10.1073/pnas.0710355105
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
D. Wermeling (2008)
10.1021/acs.nanolett.8b01071
Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy.
Keman Cheng (2018)
10.1158/1078-0432.CCR-08-0229
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
M. Sitkovsky (2008)
10.1016/j.ebiom.2015.01.011
2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
P. Ascierto (2015)
10.1039/C3TB20858C
Interaction of Ru(phen)3Cl2 with graphene oxide and its application for DNA detection both in vitro and in vivo.
H. Li (2013)
10.1039/c7sc04853j
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy† †Electronic supplementary information (ESI) available: Tables S1–S3 and Fig. S1–S6. See DOI: 10.1039/c7sc04853j
P. Zhao (2018)
10.1016/j.jconrel.2015.06.028
Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
O. V. Markov (2015)
10.1016/J.BIOMATERIALS.2003.09.083
Layered double hydroxide as an efficient drug reservoir for folate derivatives.
J. Choy (2004)
10.1016/j.jconrel.2017.04.027
Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA‐based cationic nanoparticles
Hae-yong Seok (2017)
10.1016/S1357-4310(99)01615-9
Causes and consequences of tumour acidity and implications for treatment.
M. Stubbs (2000)
10.1038/nrg2432
DNA vaccines: ready for prime time?
M. Kutzler (2008)
10.1038/s41565-018-0171-6
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
M. Tonigold (2018)
10.1038/ncomms13193
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Q. Chen (2016)
10.1002/adma.201705660
Nanomaterials for Cancer Precision Medicine.
Yilong Wang (2018)
10.1016/j.jconrel.2017.04.025
Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy
Naomi O. Hodgins (2017)
10.1016/j.biomaterials.2017.02.018
Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
Ping Huang (2017)
10.1016/j.actbio.2014.09.019
Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity.
Ping-Lun Jiang (2015)
10.1016/j.ijpharm.2016.09.057
Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
Nirmal Marasini (2016)
10.1016/S1470-2045(03)01282-8
Excisional surgery for cancer cure: therapy at a cost.
J. Coffey (2003)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.1038/nbt.3071
Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
J. Kim (2015)
10.1038/s41467-017-01386-7
Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
Guizhi Zhu (2017)
10.4049/jimmunol.1402200
Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid
Ana C. Parente-Pereira (2014)
10.3892/ETM.2012.498
Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective.
D. Zippel (2012)
10.3390/nano7060147
ZnO Nano-Rod Devices for Intradermal Delivery and Immunization
T. R. Nayak (2017)
10.1021/acs.molpharmaceut.6b01003
Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination
Mazda Rad-Malekshahi (2017)
10.1039/c4bm00427b
Lipid-coated polymeric nanoparticles for cancer drug delivery.
S. Krishnamurthy (2015)
10.1016/j.jconrel.2016.05.008
A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.
Kuan-Yin Shen (2016)
10.1002/advs.201500223
Biodegradable and Renal Clearable Inorganic Nanoparticles
E. Ehlerding (2016)
10.1016/j.biomaterials.2016.04.040
In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging.
Kvar C.L. Black (2016)
10.1021/ACSBIOMATERIALS.7B00438
Femtosecond-Laser-Based 3D Printing for Tissue Engineering and Cell Biology Applications.
Chee Meng Benjamin Ho (2017)
10.4049/jimmunol.175.2.633
DNA Vaccines: Progress and Challenges1
J. Donnelly (2005)
10.1038/nrc3239
The blockade of immune checkpoints in cancer immunotherapy
D. Pardoll (2012)
10.1016/j.juro.2012.08.169
Re: Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
S. Taneja (2012)
10.1016/j.ccell.2015.03.001
Immune checkpoint blockade: a common denominator approach to cancer therapy.
S. Topalian (2015)
10.1016/j.acra.2016.11.021
Role of Imaging in the Era of Precision Medicine.
A. Giardino (2017)
10.1093/ANNONC/MDH097
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
M. O'Brien (2004)
10.1016/0165-2478(90)90074-Z
Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2.
J. Bubenı́k (1990)
10.1023/B:PHAM.0000045235.86197.ef
Enhancement of Topical Delivery from Biodegradable Nanoparticles
Rocx00EDo Alvarez-Romx00E1n (2004)
10.1039/C7TB00819H
MgAl-layered double hydroxide nanoparticles co-delivering siIDO and Trp2 peptide effectively reduce IDO expression and induce cytotoxic T-lymphocyte responses against melanoma tumor in mice.
Ling-xiao Zhang (2017)
10.1007/s11095-010-0241-4
Nanoparticle Delivery Systems in Cancer Vaccines
Yogita Krishnamachari (2010)
10.1038/s41467-017-01830-8
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
D. Schmid (2017)
10.1111/j.1749-6632.1978.tb22034.x
LIPOSOMES IN THERAPEUTIC AND PREVENTIVE MEDICINE: THE DEVELOPMENT OF THE DRUG‐CARRIER CONCEPT
G. Gregoriadis (1978)
10.1021/bm500502n
Thermoreversible Poly(ethylene glycol)-g-Chitosan Hydrogel as a Therapeutic T Lymphocyte Depot for Localized Glioblastoma Immunotherapy
Ching-Ting Tsao (2014)
10.1142/S108842461100332X
FERROCHELATASE: THE CONVERGENCE OF THE PORPHYRIN BIOSYNTHESIS AND IRON TRANSPORT PATHWAYS.
G. A. Hunter (2011)
10.1016/j.biomaterials.2017.09.017
Nanomaterials for cancer immunotherapy.
W. Song (2017)
10.1002/adhm.201200138
Erythrocyte-inspired delivery systems.
C. Hu (2012)
10.1016/j.biomaterials.2010.09.001
Influence of degradation on inflammatory profile of polyphosphazene coated PMMA and trisacryl gelatin microspheres in a sheep uterine artery embolization model.
V. Verret (2011)
10.1016/j.canlet.2014.09.016
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
S. Shariat (2014)
10.1002/anie.201402002
Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery.
Y. Fang (2014)
10.1056/NEJMoa1412082
Nivolumab in previously untreated melanoma without BRAF mutation.
C. Robert (2015)
10.1016/j.biomaterials.2016.06.032
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
Xiao Zhao (2016)
10.1002/adhm.201700207
A Freeze‐Concentration and Polyampholyte‐Modified Liposome‐Based Antigen‐Delivery System for Effective Immunotherapy
Sana Ahmed (2017)
10.1016/j.biomaterials.2015.09.031
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth.
Jaina M Patel (2016)
10.1021/acsnano.8b01186
π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Jin-Yue Zeng (2018)
10.1021/acs.analchem.5b04031
Multimodal Detection of a Small Molecule Target Using Stimuli-Responsive Liposome Triggered by Aptamer–Enzyme Conjugate
Hang Xing (2016)
10.1016/j.biomaterials.2018.05.015
Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.
Ling-xiao Zhang (2018)
10.1039/c5cc02887f
Recent applications of carbon nanomaterials in fluorescence biosensing and bioimaging.
J. Wen (2015)
10.1038/nrd3499
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Jin-Wook Yoo (2011)
10.1016/J.ADDR.2007.06.003
Biodegradable nanoparticles for cytosolic delivery of therapeutics.
Jaspreet K. Vasir (2007)
10.1038/nmat4822
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai (2017)
10.1007/s11095-012-0738-0
Near-Infrared Image-Guided Delivery and Controlled Release Using Optimized Thermosensitive Liposomes
D. Turner (2012)
10.1016/j.abb.2018.02.015
Ferrochelatase π-helix: Implications from examining the role of the conserved π-helix glutamates in porphyrin metalation and product release.
Mallory E. Gillam (2018)
10.1080/1061186X.2018.1424857
Liposomal formulation of glycosphingolipids from Sphingomonas paucimobilis induces antitumour immunity in mice
M. Khan (2018)
10.1038/s41467-017-01050-0
Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
Guangbao Yang (2017)
10.1002/ijc.23192
Chronic inflammation and oxidative stress in human carcinogenesis
A. Federico (2007)
10.1016/j.biomaterials.2016.09.031
Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
Masaki Morishita (2016)
10.1002/ADFM.201502139
Induction of Potent Antitumor Immunity by Sustained Release of Cationic Antigen from a DNA‐Based Hydrogel with Adjuvant Activity
Yuka Umeki (2015)
10.1023/A:1018901302450
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
10.1016/j.ijpharm.2012.12.001
Glycopolymer micelles with reducible ionic cores for hepatocytes-targeting delivery of DOX.
Y. Wang (2013)
10.1021/acsnano.5b02014
Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
Jian Xiang (2015)
10.1016/j.biomaterials.2015.04.003
Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.
Michael Mchugh (2015)
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
A. Lamprecht (2001)
10.1021/nl8019888
Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery.
Thomas T. Morgan (2008)
10.1016/j.msec.2015.08.006
IR 820 dye encapsulated in polycaprolactone glycol chitosan: Poloxamer blend nanoparticles for photo immunotherapy for breast cancer.
P. Kumar (2015)
10.1038/nrc1256
Tumour-educated macrophages promote tumour progression and metastasis
J. Pollard (2004)
10.1021/JA0459936
Raman imaging of PLGA microsphere degradation inside macrophages.
A. V. van Apeldoorn (2004)
10.1189/jlb.1212631
At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy
M. Callahan (2013)
10.1016/S0378-5173(99)00186-6
Bioavailability of starch based hot stage extrusion formulations.
D. Henrist (1999)
10.1016/j.biomaterials.2016.08.022
Recent advances in different modal imaging-guided photothermal therapy.
Q. Chen (2016)
10.1016/0092-8674(82)90219-7
Rapid acidification of endocytic vesicles containing α2-macroglobulin
B. Tycko (1982)
10.1021/acsnano.6b08152
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth.
A. Kosmides (2017)
10.1016/j.biomaterials.2017.11.021
Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.
Zongmin Zhao (2018)
10.15252/embj.201490147
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer
N. Antonio (2015)
10.7150/thno.20745
Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy
Hanmei Li (2017)
10.1016/j.actbio.2018.11.009
Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
J. Wen (2019)
10.1021/nn304862b
PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.
Brian M Barth (2013)
10.1016/j.biomaterials.2012.06.059
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Y. Chen (2012)
10.1084/jem.20100031
Regulation of T cell receptor signaling by activation-induced zinc influx
Mingcan Yu (2011)
10.1002/adma.201601902
Intelligent Albumin-MnO2 Nanoparticles as pH-/H2 O2 -Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy.
Q. Chen (2016)
10.1002/ADFM.201600676
Modulation of Hypoxia in Solid Tumor Microenvironment with MnO2 Nanoparticles to Enhance Photodynamic Therapy
W. Zhu (2016)
10.1021/acsnano.7b08148
Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
Honglin Jin (2018)
10.1016/j.ijpharm.2014.09.005
Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes.
M. Yoshida (2014)
10.1002/adma.201706098
A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy.
Yu Mi (2018)
10.1038/nature10169
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
A. Facciabene (2011)
10.1021/acs.biomac.5b01150
Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG-PLA Conjugate for Tuning Immunity.
Fanny Coumes (2015)
10.1016/j.biomaterials.2013.07.099
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.
Parag Parekh (2013)
10.1016/j.jconrel.2016.02.018
Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
E. Varypataki (2016)
10.1186/1477-3155-9-55
Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines
A. Mahapatro (2011)
10.1021/jacs.6b06663
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
Kuangda Lu (2016)
10.1002/ijc.28858
Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70
M. Shevtsov (2014)
10.1016/J.JCONREL.2005.07.013
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.
L. Costantino (2005)
10.1084/JEM.172.4.1217
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
B. Gansbacher (1990)
10.1038/nnano.2016.168
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.
S. Zanganeh (2016)
10.1016/j.jconrel.2013.03.010
Immune system targeting by biodegradable nanoparticles for cancer vaccines.
J. M. Silva (2013)
10.1002/smll.201402369
Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation.
R. A. Meyer (2015)
10.1146/ANNUREV.IY.13.040195.002151
Paracrine cytokine adjuvants in cancer immunotherapy.
D. Pardoll (1995)
10.1021/ja200328s
pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Faheem Muhammad (2011)
10.2217/nnm.12.142
T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles.
Akira Ito (2013)
10.1021/acs.nanolett.6b01994
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.
D. Wang (2016)
10.1016/S0140-6736(14)60958-2
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
C. Robert (2014)
10.1021/ja211035w
Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
Limin Pan (2012)
10.1016/j.biomaterials.2016.01.029
Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics.
S. Ishii (2016)
10.1021/acs.chemrev.7b00094
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment.
G. Huang (2017)
10.1039/C2JM34364A
Dissolution from inside: a unique degradation behaviour of core–shell magnetic mesoporous silica nanoparticles and the effect of polyethyleneimine coating
K. Chen (2012)
10.1021/acs.nanolett.7b03734
Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
J. W. Hickey (2017)
10.1021/nn500216y
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu (2014)
10.1002/ADFM.201501031
Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking
Changqiang Wu (2015)
10.1021/ja5029364
Activatable fluorescence/MRI bimodal platform for tumor cell imaging via MnO2 nanosheet-aptamer nanoprobe.
Zilong Zhao (2014)
10.1021/ja803947s
Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications.
E. Bachelder (2008)
10.1016/j.biomaterials.2015.02.125
Enhanced immunostimulatory effects of DNA-encapsulated peptide hydrogels.
S. Medina (2015)
10.1038/nri1415
Inflammation and necrosis promote tumour growth
J. Vakkila (2004)
10.1016/j.biomaterials.2015.11.040
Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation.
C. Wang (2016)
10.1002/adma.201704408
Antigen-Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal-Immunotherapy.
Jinbin Pan (2018)
10.1016/j.ijpharm.2013.04.051
Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres.
H. Zhao (2013)
10.1016/j.biomaterials.2016.03.007
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy.
T. Lozano (2016)
10.1002/jbm.a.36151
Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors.
Joshua M. Gammon (2017)
10.1016/j.jconrel.2015.10.051
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
M. Shevtsov (2015)
10.7150/thno.19894
Self-Assembly DNA Polyplex Vaccine inside Dissolving Microneedles for High-Potency Intradermal Vaccination
Jing-Fong Liao (2017)
10.1021/acsami.7b05890
Self-Assembled DNA Dendrimer Nanoparticle for Efficient Delivery of Immunostimulatory CpG Motifs.
Yijiao Qu (2017)
10.1016/j.biomaterials.2013.05.020
The use of a near-infrared RNA fluorescent probe with a large Stokes shift for imaging living cells assisted by the macrocyclic molecule CB7.
Z. Li (2013)
10.1016/j.biomaterials.2016.10.047
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Gaona Shi (2017)
10.1002/adma.201400815
Monodispersed and ordered large-pore mesoporous silica nanospheres with tunable pore structure for magnetic functionalization and gene delivery.
Dechao Niu (2014)
10.1002/ADFM.201604366
Localized Multi-Component Delivery Platform Generates Local and Systemic Anti-Tumor Immunity
A. P. Acharya (2017)
10.1002/eji.201343794
Microsphere priming facilitates induction of potent therapeutic T‐cell immune responses against autochthonous liver cancers
Benjamin Brinkhoff (2014)
10.1039/C5TB00703H
Acid degradable poly(vinylcaprolactam)-based nanogels with ketal linkages for drug delivery.
Y. Wang (2015)
10.1002/ADFM.201102052
Engineering Inorganic Nanoemulsions/Nanoliposomes by Fluoride‐Silica Chemistry for Efficient Delivery/Co‐Delivery of Hydrophobic Agents
Y. Chen (2012)
10.1056/NEJMoa1200690
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
S. Topalian (2012)
10.1002/JBM.A.30853
Macrophage-mediated biodegradation of poly(DL-lactide-co-glycolide) in vitro.
Zhidao Xia (2006)
10.1002/adhm.201400137
Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs.
R. Pompano (2014)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.1002/JPS.1023
Trends and developments in liposome drug delivery systems.
T. Lian (2001)
10.1021/acs.nanolett.6b03329
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.
Matthias Oberli (2017)
10.1021/acsnano.6b04989
Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors.
Yanqi Ye (2016)
10.1016/J.CARBON.2014.01.029
Interaction of propidium iodide with graphene oxide and its application for live cell staining
F. Liu (2014)
10.1038/nature23669
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra (2017)
10.1002/ADFM.201501712
Development of a Multifunctional Platform Based on Strong, Intrinsically Photoluminescent and Antimicrobial Silica‐Poly(citrates)‐Based Hybrid Biodegradable Elastomers for Bone Regeneration
Y. Du (2015)
10.1158/0008-5472.CAN-12-4561
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.
Uma Prabhakar (2013)
10.1039/C6CS00458J
Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
C. Liang (2016)
10.1021/acs.nanolett.5b00570
Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy.
Q. Hu (2015)
10.1016/j.biomaterials.2008.07.050
Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.
Y. Wang (2008)
10.1111/j.1600-065X.2009.00765.x
Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges
C. Wang (2009)
10.1021/acsnano.7b06094
Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific Immunomodulators.
C. Zamecnik (2017)
10.1016/j.biomaterials.2018.01.004
Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma.
Huijuan Song (2018)
10.1002/anie.201800422
A Cisplatin-Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy.
N. Wang (2018)
10.1158/0008-5472.CAN-07-1565
Targeting cancer with bugs and liposomes: ready, aim, fire.
Ian Cheong (2007)
10.1021/BM015548S
Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH.
N. Fang (2001)
10.1021/acs.accounts.7b00339
High-Density Lipoprotein Nanobiologics for Precision Medicine.
W. Mulder (2018)
10.1080/2162402X.2015.1123368
An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs
M. Hirayama (2016)
10.1007/s00262-017-2016-9
Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model
L. Zhang (2017)
10.1016/j.biomaterials.2013.11.004
Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide.
Wei-Lin Chen (2014)
10.1016/j.biomaterials.2017.09.031
Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
Carolina Mora-Solano (2017)
10.1039/c7cs00219j
Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems.
J. Wen (2017)
10.1021/acs.nanolett.6b04150
Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control.
Zipeng Zhen (2017)
10.1021/acsnano.7b07384
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.
Q. Liu (2018)
10.1073/pnas.1706527114
Effective intermediate-spin iron in O2-transporting heme proteins
Nils Schuth (2017)
10.1016/j.bbrc.2015.11.084
Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.
Tatsuaki Iwama (2016)
10.1002/adma.201606034
van der Waals Metal-Organic Framework as an Excitonic Material for Advanced Photonics.
V. Milichko (2017)
10.1021/nl404316v
Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres.
D. Shen (2014)
10.1021/acsnano.5b01042
Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Y. Guo (2015)
10.1038/nnano.2007.149
Bacteria-mediated delivery of nanoparticles and cargo into cells.
D. Akin (2007)
10.1007/S12094-008-0172-2
Photodynamic therapy of cancer. Basic principles and applications
Á. Juarranz (2008)
10.1002/adma.201506312
Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.
C. Wang (2016)
10.1007/S10856-006-6816-2
Degradation behavior of hydrophilized PLGA scaffolds prepared by melt-molding particulate-leaching method: Comparison with control hydrophobic one
S. Oh (2006)
10.1007/s12094-015-1295-x
Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells
D. Miguel (2015)
10.1002/ADFM.201603651
Immune Complexes Mimicking Synthetic Vaccine Nanoparticles for Enhanced Migration and Cross‐Presentation of Dendritic Cells
S. Kim (2016)
10.1177/0885328217704139
pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization
Jianye Wei (2017)
10.1038/nmat3095
In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging
N. Artzi (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar